Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$147,495,727
+$42,470,660 QoQ
Shares Held
2,814,804
-5.2% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#14
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 72%
None 28%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,379,025 | $747,197,111 | |
| 2 | ZTS |
Zoetis Inc.
|
9,423,895 | $677,201,094 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,671,157 | $259,898,795 | |
| 4 | ALKS |
Alkermes plc.
This page
|
2,814,804 | $147,495,727 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,013,063 | $112,389,207 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,676,050 | $65,857,589 | |
| 7 | HLN |
Haleon plc
|
3,273,583 | $30,542,527 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,365,103 | $18,731,613 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,495,727 | 2,814,804 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $105,025,067 | 2,970,166 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $84,511,963 | 3,020,442 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,255,700 | 375,190 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $48,639,943 | 1,700,103 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $102,258,941 | 3,096,879 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $201,679,008 | 7,012,483 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $354,304,275 | 12,658,245 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $345,949,521 | 14,354,752 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $403,136,180 | 14,892,360 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $422,798,375 | 15,241,470 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $329,027,642 | 11,746,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $240,724,103 | 7,690,866 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $189,164,341 | 6,710,335 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $157,939,593 | 6,044,378 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $150,111,300 | 6,722,405 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $177,400,400 | 5,955,032 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $302,026,722 | 11,479,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $274,659,243 | 11,808,222 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $364,165,566 | 11,808,222 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $348,959,736 | 14,231,637 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $383,452,370 | 20,527,429 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $409,731,083 | 20,537,899 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $425,539,653 | 21,923,733 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $316,267,829 | 21,932,582 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||